COHEN FRED E received a stock award from KYVERNA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/29/2026ACC: 0001193125-26-248434
Director10% Owner
Since Feb 2024
+25.68K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
25.68K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.09K
Price / share
—
Trade value
—
% of position
30.6%
5/27/2026
16.63K→21.73K
Total
Net shares
+5.09K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/27/2026 | A · Award | +5.09K | — | — | 30.6% | 16.63K | 21.73K |
| Total | +5.09K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
20.58K shares
Shares
+20.58K
Strike price
8.59
Held after
20.58K
Exercisable
—
5/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock20.58K shares | 5/27/2026 | A · Award | +20.58K | 8.59 | — | 20.58K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4.52M
Total
4.52M indirect4.52M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.52M | Indirect |
| Total | 4.52M | 4.52M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported